Sekisui XenoTech, LLC
Sekisui XenoTech, LLC is an entity about which the provided input dataset contains no substantive operational, product, financial, or strategic information beyond its legal name and an "operating" status flag; no products, customers, revenue, or technology details are documented.
- Company typePrivate
- Founded1994
- HeadquartersKansas City, United States
- Headcount101–250
- GTM typeB2B
- OfferingServices
Sekisui XenoTech, LLC firmographics
Firmographics- Name
- Sekisui XenoTech, LLC
- Website
- https://xenotech.com
- Company type
- Private
- Founded year
- 1994
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Short description
- Sekisui XenoTech, LLC is an entity about which the provided input dataset contains no substantive operational, product, financial, or strategic information beyond its legal name and an "operating" status flag; no products, customers, revenue, or technology details are documented.
- Ownership category
- akta.pro rank
Sekisui XenoTech, LLC industry classification
Industry- Product category
- Contract Research Organization / Preclinical ADME Services
- NAICS
- Other Scientific and Technical Consulting Services (54169)
- SIC
- Medicinal Chemicals & Botanical Products (2833)
- akta.pro primary industry
- Data Management, Reporting & Regulatory Submissions for Central Labs (HLAGAEAL)
Keywords
Where Sekisui XenoTech, LLC is headquartered
LocationHeadquarters
- HQ city
- Kansas City
- HQ country
- United States
- HQ region
- North America
Markets served
Sekisui XenoTech, LLC business model
Business model- GTM type
- B2B
- Offering type
- Services
Sekisui XenoTech, LLC product offering
Product offeringCore offering
No substantive description of core offerings is supported by the provided source data. The input contains no descriptive text or resolvable source IDs about Sekisui XenoTech, LLC's products or services.
Differentiator
Problem solved
Functional benefit
Sekisui XenoTech, LLC technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Sekisui XenoTech, LLC competitors and assessment
Company assessmentDirect peers
- Inotiv: U.S. preclinical CRO offering DMPK, ADME, safety assessment, and research models. Closely comparable in scale and service mix to Sekisui XenoTech's preclinical drug-metabolism focus.
- Cyprotex (an Evotec company): Specialized ADME/DMPK CRO with in vitro and in vivo services almost identical in scope to Sekisui XenoTech. Most direct specialty competitor in preclinical drug metabolism, now part of Evotec.
- Absorption Systems: Specialty CRO focused on in vitro ADME, drug-drug interactions, and pharmacokinetics — historically one of the closest U.S. comparables to Sekisui XenoTech's preclinical DMPK niche.
Broad incumbents
- Charles River Laboratories: Large global CRO with a major preclinical and safety-assessment franchise including DMPK/ADME services. Directly comparable to Sekisui XenoTech in the ADME/preclinical drug metabolism category, but materially larger and diversified across research models, manufacturing, and discovery.
- Labcorp Drug Development (formerly Covance): One of the largest global CROs offering preclinical ADME, DMPK, and bioanalytical services. Comparable to Sekisui XenoTech in preclinical DMPK/ADME offerings, but operates as a much broader full-service drug-development platform.
- WuXi AppTec: Asia-based global CRO with extensive preclinical DMPK/ADME capabilities and a large U.S. lab footprint. Comparable to Sekisui XenoTech in ADME services, but with a far broader discovery-through-manufacturing platform.
- Eurofins Scientific: Global life-sciences testing group with substantial DMPK, ADME, and bioanalytical service lines. Comparable in preclinical ADME service scope, but operates a much wider portfolio of food, environmental, and pharma testing.
Emerging players
- Pharmaron: China-headquartered CRO with growing preclinical ADME/DMPK capabilities in the U.S. and UK. Comparable service offering, but with broader integrated discovery-through-development positioning.
- Frontage Laboratories: Contract research organization providing bioanalytical, DMPK, and CMC services. Comparable ADME/DMPK service scope, with additional bioanalytical and clinical laboratory offerings.
- BioDuro (a Tigermed company): China-rooted CRO offering preclinical DMPK/ADME and discovery services to global biopharma. Comparable in ADME offering, with broader discovery and integrated drug-development capabilities.
Market position
Customer concentration
Sekisui XenoTech, LLC social profiles
Digital presenceSekisui XenoTech, LLC financial estimates
Financial estimateRevenue estimate
Valuation estimate
Sekisui XenoTech, LLC leadership team
Management profileNumber of profiles
Sekisui XenoTech, LLC funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Sekisui XenoTech, LLC M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Sekisui XenoTech, LLC
What does Sekisui XenoTech, LLC do?
No substantive description of core offerings is supported by the provided source data. The input contains no descriptive text or resolvable source IDs about Sekisui XenoTech, LLC's products or services.
Is Sekisui XenoTech, LLC a public or private company?
Sekisui XenoTech, LLC is a private company. It is classified as unknown and is currently operating.
When was Sekisui XenoTech, LLC founded?
Sekisui XenoTech, LLC was founded in 1994. It employs 101 to 250 people.
Where is Sekisui XenoTech, LLC based?
Sekisui XenoTech, LLC is headquartered in Kansas City, United States, in the North America region.
Who are Sekisui XenoTech, LLC's main competitors?
Direct peers on record are Inotiv, Cyprotex (an Evotec company) and Absorption Systems. Broad incumbents are Charles River Laboratories, Labcorp Drug Development (formerly Covance), WuXi AppTec and Eurofins Scientific. Emerging players are Pharmaron, Frontage Laboratories and BioDuro (a Tigermed company).
Does Sekisui XenoTech, LLC have an API?
No public API is recorded for Sekisui XenoTech, LLC.
What industry is Sekisui XenoTech, LLC in?
Sekisui XenoTech, LLC's product category is Contract Research Organization / Preclinical ADME Services. Its primary akta.pro industry code is HLAGAEAL, Data Management, Reporting & Regulatory Submissions for Central Labs. Its NAICS code is 54169 and its SIC code is 2833.